4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-21-017484
Chief Operating Officer sold 14,500 shares at an average $45.88 ($665,290)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nabulsi Azmi Chief Operating Officer | 2021-03-01 | Sale | −3,825 | $45.77 | $175,069 | 805,375 | I |
| Nabulsi Azmi Chief Operating Officer | 2021-03-01 | Sale | −1,548 | $46.05 | $71,293 | 803,827 | I |
| Nabulsi Azmi Chief Operating Officer | 2021-03-02 | Sale | −600 | $44.60 | $26,757 | 803,227 | I |
| Nabulsi Azmi Chief Operating Officer | 2021-03-02 | Sale | −4,833 | $46.16 | $223,080 | 798,394 | I |
| Nabulsi Azmi Chief Operating Officer | 2021-03-02 | Sale | −24 | $46.73 | $1,122 | 798,370 | I |
| Nabulsi Azmi Chief Operating Officer | 2021-03-02 | Sale | −1,600 | $45.17 | $72,276 | 796,770 | I |
| Nabulsi Azmi Chief Operating Officer | 2021-03-02 | Sale | −2,070 | $46.23 | $95,695 | 794,700 | I |
| Open-market sales · 14,500 sh · avg $45.88 · $665,290 | |||||||
Loading xslF345X03/doc4.xml…